The ubiquitin-editing enzyme A20 (tumor necrosis factor-a-induced protein 3) serves as a critical brake on nuclear factor jB (NF-jB) signaling. In humans, polymorphisms in or near the A20 gene are associated with several inflammatory disorders, including psoriasis. We show here that epidermis-specific A20-knockout mice (A20 EKO ) develop keratinocyte hyperproliferation, but no signs of skin inflammation, such as immune cell infiltration. However, A20 EKO mice clearly developed ectodermal organ abnormalities, including disheveled hair, longer nails and sebocyte hyperplasia. This phenotype resembles that of mice overexpressing ectodysplasin-A1 (EDA-A1) or the ectodysplasin receptor (EDAR), suggesting that A20 negatively controls EDAR signaling. We found that A20 inhibited EDAR-induced NF-jB signaling independent from its de-ubiquitinating activity. In addition, A20 expression was induced by EDA-A1 in embryonic skin explants, in which its expression was confined to the hair placodes, known to be the site of EDAR expression. In summary, our data indicate that EDAR-induced NF-jB levels are controlled by A20, which functions as a negative feedback regulator, to assure proper skin homeostasis and epidermal appendage development. Cell Death and Differentiation (2011) 18, 1845-1853; doi:10.1038/cdd.2011.55; published online 13 May 2011
The epidermis consists mainly of keratinocytes organized in different layers. The basal layer keratinocytes are mitotically active and provide new cells that gradually undergo differentiation toward the skin surface where they cornify and are shed. This well-orchestrated biological process is tightly controlled, and distortions in the sequence of events can result in different skin disorders, including inflammation and cancer. An exact control of the transcription factor nuclear factor kB (NF-kB) is essential to maintain skin homeostasis, witnessed by the fact that NF-kB overactivity as well as the ablation of essential NF-kB activators lead to skin inflammation. [1] [2] [3] NF-kB belongs to a family of structurally related and evolutionarily conserved proteins (p100 or NF-kB2, p105 or NF-kB1, p65 or RelA, RelB, c-Rel), which exist as homo-or heterodimers. In resting cells, NF-kB is kept inactive by binding to inhibitor of kB (IkB) proteins, of which IkBa is the most studied. Numerous stimuli lead to phosphorylation and polyubiquitination of IkB proteins, which targets them for proteasomal degradation. This results in the release of NF-kB, which accumulates in the nucleus and transcriptionally activates target genes.
A central event in NF-kB signaling is the activation of the IkB kinase (IKK) complex, which consists of two kinases, IKK1
and IKK2 (also known as IKKa and IKKb), and a regulatory platform protein, NF-kB essential modulator (NEMO, also known as IKKg). Gene targeting experiments showed that IKK2 and NEMO, but not IKK1, are required for NF-kB activation by tumor necrosis factor (TNF) and by Toll-like receptors. 3 Some receptors, such as those for lymphotoxin b and CD40, can activate an alternative NF-kB pathway involving IKK1 and leading to processing of p100 NF-kB to p52, which forms a transcriptionally active dimer with RelB.
As shown by skin-specific ablation of different NF-kB activators, cell autonomous activity of NF-kB seems to prevent keratinocyte apoptosis in both homeostatic and TNF-dependent inflammatory conditions. 2 As expected, overactivation of NF-kB in keratinocytes results in skin inflammation. Besides its role in controlling inflammation and preventing apoptosis, NF-kB is also involved in the development of epidermal derivatives, such as hair, nails and sweat glands, 4, 5 in which signaling is initiated by the binding of ectodysplasin-A1 (EDA-A1) to the epidermal-specific TNF-R family member ectodysplasin receptor (EDAR). 6, 7 EDAR acts through ectodysplasin receptor-associated adapter protein (EDARADD), TRAF6 and TAB2/TAK1 to activate the IKK complex. 8 Human mutations in the Eda1, Edar or Edaradd genes result in hypohidrotic ectodermal dysplasia (HED) characterized by defects in development of hair, teeth and sweat glands. 8, 9 Similarly, mice carrying mutations in these genes, or lacking them or Traf6, acquire HED. [10] [11] [12] [13] [14] [15] [16] Transgenic mice overexpressing EDA-A1 or EDAR develop morphogenetic alterations in a variety of ectodermal organs, including hair and teeth, and sweat, mammary and sebaceous glands, [17] [18] [19] [20] [21] [22] which indicates that overactivation of the EDA/EDAR pathway is detrimental for the development of epidermal appendages.
As NF-kB is crucial in development and inflammation, tight regulation of its activation is essential. This tight control is achieved by the combined action of positive and negative regulators. During recent years, ubiquitination and deubiquitination (DUB) of several NF-kB signaling components have been identified as crucial steps in the control of NF-kB signaling pathways. 23 One critical brake on NF-kB activation is the ubiquitin-editing enzyme A20, which has been characterized as an inhibitor of both NF-kB activation and apoptosis. A20 is required for terminating NF-kB signaling in response to TNF and microbial products, such as lipopolysaccharide and muramyl dipeptide. The in vivo importance of the A20 anti-inflammatory activities is illustrated by severe multi-organ inflammation and perinatal death seen in A20 À/À mice. 24 Recent genetic studies demonstrate an association between the human A20/tumor necrosis factor-a-induced protein 3 (TNFAIP3) gene and autoimmune pathology and psoriasis, which suggests that A20 might have an important role in human autoimmune and inflammatory diseases. 25 These findings emphasize the importance of A20 in the control of normal tissue homeostasis and identify it as a potential target for the treatment of multiple inflammatory pathologies, including psoriasis.
We used K14-driven Cre/LoxP-mediated gene targeting in mice to investigate the in vivo function of A20 in epidermal development and homeostasis. We show that A20 is essential for controlling keratinocyte proliferation and for proper development of ectodermal appendages. Our data indicate that keratinocyte-specific deletion of A20 results in excessive EDA-A1-induced NF-kB signaling, thereby phenocopying EDA-A1 transgenic mice.
Results
Generation of epidermis-specific A20-deficient mice. To identify the tissue-specific functions of A20, we generated mice carrying a conditional A20 allele in which exons IV and V of the mouse A20 gene are flanked by LoxP sites. 26 To study the function of A20 in skin and epidermal appendages, we crossed the A20 FL/FL mice with a transgenic mouse line that expresses Cre under the control of the human keratin 14 gene promoter (K14-Cre). 27 Epidermal keratinocyte-specific A20-knockout mice (A20 EKO ) were born with normal Mendelian segregation (data not shown). To verify keratinocyte-specific A20 deletion in A20 EKO mice (Figure 1a) , we confirmed by Southern blot analysis that there was efficient Cre-mediated recombination in epidermis and in primary keratinocytes (Figure 1b) . Consequently, we could not detect endogenous A20 in epidermal extracts from A20 EKO mice (Figure 1c ).
A20
EKO mice show keratinocyte hyperplasia. Macroscopic signs of skin inflammation, such as redness, scaling or excessive scratching due to itch, were not observed in A20 EKO mice (Figure 1a ). Histological analysis of back skin sections showed a thickened epidermis because of the increased proliferation (2.5-fold) of the basal cells (Figure 2 ), but similar very low levels of apoptosis (data not shown). The expression patterns of the differentiation markers caspase-14, filaggrin and keratin 10 were normal, and infiltrating immune cells were not observed (data not shown). These data indicate that absence of A20 does not lead to spontaneous skin inflammation, or that other DUB enzymes, such as cylindromatosis (CYLD), 28 act redundantly to prevent spontaneous inflammation. (Figures 1a and 3a) . This disheveled hair phenotype was never observed in A20 FL/FL control littermates. Mice were monitored up to the age of 12 months and did not exhibit signs of hair loss or alopecia. A20 FL/FL mice were also crossed to a K5-Cre transgenic line, 29 with which a similar phenotype was observed (data not shown). All further experiments were carried out on A20 FL/FL /K14-Cre mice. 27 Four hair types can be distinguished in the mouse coat. Awl and guard hairs are straight, whereas auchene and zigzag hairs have one or multiple bends, respectively. Although straight hairs were found in A20 EKO mice, other hair types had a curly instead of a bended morphology (Figure 3b ). On epilating A20 EKO mice, we noticed that the hair was more fragile and thinner than the hair of A20 FL/FL mice. The increased fragility of A20 EKO hair was further confirmed by testing its resistance to sonication (data not shown). Scanning electron microscopy (SEM) analysis confirmed extensive cuticle damage in hair fibers of A20 EKO mice (Figures 3c  and d ). This hair damage can be explained by the amorphous nature of the hair cuticle, which, as observed by transmission electron microscopy, lacked a clear structure (Figures 3e and f) . The medulla of the A20 EKO hair is similar to that of A20 FL/FL mice (data not shown). The A20 EKO hair phenotype is strikingly similar to that of mice with keratinocyte-specific transgenes for EDA-A1 or EDAR. [17] [18] [19] 30, 31 The EDA-A1-induced NF-kB pathway is required for the development of epidermal appendages, including hair, and its hyperactivity results in disheveled hair, longer nail growth, sebocyte A20 acts as a regulator of the EDA pathway to NF-jB activation. As the loss of A20 in the skin results in partial phenocopy of epidermis-specific EDA-A1 overexpressing mice we hypothesized that A20 might be a negative regulator of the EDA pathway. Indeed, by using an NF-kB-dependent luciferase (Luc) reporter assay, we demonstrated that A20 blocks EDAR-induced activation of NF-kB in HEK293T cells to a similar extend as TNF-induced NF-kB activation (Figure 5a ). Making use of deletion mutants, we could demonstrate that EDAR-induced NF-kB activation was inhibited by the C-terminal domain of A20, containing the Zn-fingers, but not by the N-terminal DUB domain ( Figure 5b and Supplementary Figure 1) , suggesting that the DUB activity is not required for inhibition of NF-kB activation.
To verify this, we also tested a double point mutant (A20 D100A/C103A), which has no DUB activity 32 ( Figure 5c and Supplementary Figure 1) . A20 D100A/C103A was as effective as wild-type A20 in inhibiting EDAR-induced NF-kB, confirming that the A20 DUB activity is not required for this effect.
In addition, both A20 mRNA and protein levels were increased after EDA-A1 treatment of embryonic skin explants of Eda-deficient mice (Tabby; hereafter Eda À/À , Figures 5d and e). This indicates that A20 is an NF-kB response gene in the EDA pathway acting in negative feedback regulation of EDAR-induced NF-kB signaling. Interestingly, the expression pattern of A20 in the skin of developing embryos (E14) appears to be limited to the hair placode (Figure 6a) , that is, at the sites of EDAR expression and NF-kB activity. 4, 33 This indicates that under homeostatic conditions, A20 functions mainly in the hair follicle to prevent overactivation of EDAR. We could not detect A20 in mammary buds or tooth placodes of E12 embryos (Figure 6b ). However, it was previously reported that A20 is expressed at later stages of tooth development, as well as in secondary hair follicles and vibrissae. 34 In conclusion, these data indicate that the phenotype of the A20 EKO mice is due, at least in part, to overactivity of the EDA pathway in the absence of A20.
Discussion
Similar to IkBa, A20 is an important negative regulator of NF-kB signaling and inflammation. 25 However, their modes of action are totally different. IkBa functions by binding NF-kB directly and sequestering it away from the nucleus, whereas A20 is a ubiquitin-editing enzyme that inactivates multiple targets in the NF-kB pathway. 25 IkBa is always present in unstimulated cells to restrain uncontrolled NF-kB activation in the absence of a specific inflammatory trigger. In contrast, in most unstimulated cells, expression of A20 is weak, but it is strongly induced once NF-kB signaling is switched on. As IkBa expression is further induced on NF-kB triggering, both IkBa and A20 are involved in a negative feedback loop of NF-kB activation. The hyperinflammation in IkBa or full A20 null mice, and their early death, point to critical functions of IkBa and A20 in NF-kB regulation. 24, [35] [36] [37] Excessive NF-kB signaling in the skin, such as in keratinocyte-specific IkBa-knockout mice and K5-IKK2-transgenic mice, induces skin inflammation. 37, 38 Unexpectedly, though A20 EKO mice developed epidermal hyperproliferation, they did not develop spontaneous inflammation. The presence of a functional IkBa might be sufficient to control minor inflammatory responses against environmental insults. Alternatively, redundant DUB enzymes that control NF-kB activation, such as CYLD, might be active in the skin. Although CYLD is prominently expressed in the epidermis, CYLD À/À mice do not exhibit skin abnormalities. 28 It is possible that ablation of both A20 and CYLD is required for spontaneous severe skin inflammation.
We show that epidermis-specific A20 deletion leads to multiple abnormalities in ectodermal organs, similar to overactivation of the EDA pathway. [18] [19] [20] [21] [22] 39 The resemblance of A20 EKO mice to mice overexpressing EDA-A1 or EDAR and EKO and control mice were stained with an anti-adipophillin antibody. (Scale bar: 500 mm.) (d) The surface areas of the sections through the sebaceous gland were determined based on this staining using Volocity image analysis software, and the mean surface areas in A20 EKO and control mice were compared A20 controls skin homeostasis S Lippens et al the inhibition of EDAR signaling by A20 in vitro strongly suggest that hyperactivation of the EDA pathway is the primary cause of the A20 EKO phenotype. This conclusion is further supported by our finding that EDA-A1 induces A20 expression and that A20 mRNA co-localizes with Edar and NF-kB signaling activity in developing hair follicles. A20 is known to inhibit NF-kB signaling induced by different signaling pathways, and was shown to depend on the DUB activity of its OTU domain and the ubiquitin-ligating activity of the C-terminal Zn-fingers. 40 We could demonstrate that the DUB activity of A20 is not involved in inhibition of EDAR signaling.
Similarities between A20 EKO mice and EDA-A1-transgenic mice include nail and hair defects, and sebaceous gland hyperplasia. EDA-A1 transgenics also develop extra teeth and nipples, 18 but these abnormalities were never observed in A20 EKO mice. It is possible that EDA-A1 signaling is not regulated by A20 at these sites, which correlates with the lack of detectable A20 expression in tooth placodes and mammary buds. It is also possible that formation of supernumerary tooth and mammary buds requires more potent EDAR activity, which can be achieved by excessive ligand production but not by removal of a negative feedback mechanism that attenuates signaling. Another explanation is that K14-Cre-mediated deletion of A20 may have taken place too late to allow induction of ectopic organ primordia, because K14-Cre expression is strongest at E15, whereas induction of tooth and mammary placodes starts at E11 to E12. 41 In conclusion, we identified A20 as an EDA-A1-induced protein acting as an inhibitor of EDAR-dependent NF-kB signaling, independent from its DUB activity. As a consequence, genetic deletion of A20 in keratinocytes affects normal epidermal appendage development, similar as observed in transgenic mice overexpressing EDA-A1 or EDAR.
Materials and Methods

A20
EKO and Eda À/À mice. Mice with a conditional A20 allele, in which exons IV and V of A20 are flanked with two LoxP sites, were generated as described. 26 All experiments were performed on mice backcrossed into the C57BL/6 background for at least five generations. Mice were housed in individually ventilated cages at the VIB Department for Molecular Biomedical Research in a specific pathogen-free animal facility. EDA-deficient mice were purchased from the Jackson Laboratories (Bar Harbor, ME, USA; Tabby, stock #JR0314). All experiments on mice were Southern blotting. Genomic DNA (10 mg) was digested with BamHI to differentiate between the 6.5-kb and 13.5-kb fragments of A20 FL and A20 EKO alleles, respectively. DNA was separated in agarose gels and transferred to nitrocellulose. DNA was hybridized with a 32 P-labeled probe.
Hair analysis. Hairs from A20 FL/FL and A20 EKO mice were obtained from the back and examined with a stereomicroscope.
NF-jB Luc reporter assay. Human A20 truncation mutants A20-N (AA 1-376) and A20-C (AA 377-790), and A20 D100A/C103A double mutant, with amino-terminal E-tag were cloned in the pCAGGS expression plasmid. HEK293T cells were transfected with the indicated expression vectors combined with 100 ng of reporter plasmids for NF-kB Luc and pACT-b galactosidase (Gal). After 24 h, the cells were collected, washed in PBS and lysed in Luc lysis buffer (25 mM Tris phosphate (pH 7.8), 2 mM DTT, 2 mM CDTA, 10% glycerol and 1% Triton-X-100). Substrate buffer was added (658 mM luciferin, 378 mM coenzyme A and 742 mM ATP) and Luc activity was assayed in a GloMax 96 Microplate Luminometer (Promega, Leiden, The Netherlands). b-Gal activity in cell extracts was assayed with chlorophenol red b-D-galactopyranoside substrate (Roche Applied Science, Basel, Switzerland) and the optical density was read at 595 nm in a Benchmark microplate Reader (Bio-Rad Laboratories, Nazareth, Belgium). Luc values were normalized for Gal values to correct for differences in transfection efficiency (plotted as Luc/Gal). The data represent the average ± S.D. of triplicates.
Histological and immunohistochemical analysis. Tissues were fixed for 2 h in 4% paraformaldehyde and embedded in paraffin. Sections of 5 mm were processed for immunohistochemical analysis, and anti-Ki-67 (Dako EnVision System, Glostrup, Denmark) or anti-adipophillin was used as primary antibody (Fitzgerald Industries Int., Acton, MA, USA). Whole-mount in situ hybridization was performed on E12 embryos using an anti-sense probe for A20 (left panels) or Wnt10b (right panels) as a positive control for expression in the tooth placode (upper panels) and mammary bud (lower panels). F, forelimb; H, hindlimb; I, incisor placode; m, mammary bud; M, molar placode; T, tongue A20 controls skin homeostasis S Lippens et al 319 in five A20 EKO mice. Mean surface area ± S.E.M. is shown. Statistical significance between experimental groups was assessed using an unpaired twosample Student's t-test. P-values o0.05 were considered to indicate statistical significance.
Transmission electron microscopy. Mice were anesthetized and then killed by perfusion fixation through the vascular system with 4% paraformaldehyde. After washing, skin samples were post fixed in 1% OsO 4 with K 3 Fe(CN) 6 in 0.1 M NaCacodylate buffer (pH 7.2). Samples were dehydrated through a graded ethanol series, including en-bloc staining with 2% uranyl acetate at the 50% ethanol step, and then embedded in Spurr's resin. Ultrathin sections of B150 nm were cut using an ultramicrotome (Leica EM UC6, Leica Microsystems, Mannheim, Germany), and collected on formvar-coated copper grids. They were post-stained with uranyl acetate and lead citrate in a Leica EM AC20 autostainer and viewed with a JEOL 1010 transmission electron microscope (JEOL, Tokyo, Japan) at 80 kV and digital images were captured on reusable image plates.
Scanning electron microscopy. Samples of hair for SEM were mounted on specimen stubs with double-sided tape and coated with gold using a Polaron SC 7620 Sputter coater (Quorum Technologies, East Sussex, UK). Samples were viewed with a Hitachi TM-1000 scanning electron microscope (Hitachi HighTechnologies Gmbh, Krefeld, Germany) and images were captured directly as digital files.
Skin explant culture and quantitative RT-PCR. Embryonic skin explants were cultured as previously described. 42 In brief, E14 EDA À/À back skins were dissected, cut into halves along the midline and cultured for 2 (10 samples) or 4 h (9 samples) in a 30-ml hanging drop of DMEM, 10% FCS, glutamine and penicillin-streptomycin. One-half was supplemented with 250 ng/ml of recombinant Fc-Eda-A1 protein, 43 and the control half with PBS, 0.1% BSA. For RNA isolation, skin explants were harvested in 350 ml of Rneasy (Qiagen, Venlo, The Netherlands) lysis buffer as specified by the manufacturer. Dnase-treated RNA (300 ng) was reverse transcribed with Superscript II (Invitrogen, Merelbeke, Belgium), and quantitative PCR was performed in a LightCycler480 (Roche). Transcript number was quantified by comparison with PCR product dilutions of the genes of interest using Lightcycler480 (Roche) software provided by the manufacturer. Expression of each gene was normalized against Ranbp1. The primer sequences were as follows: A20 forward: 5 0 -AGGCTATGACAGCCAGCA CT-3 0 ; A20 reverse 5 0 -AAACCTACCCCGGTCTCTGT-3 0 . Statistical significance between experimental groups was assessed using a paired Student's t-test.
In situ hybridization. Embryos were fixed overnight in 4% paraformaldehyde and dehydrated in a methanol series. Whole-mount in situ hybridization was carried out by the InSituPro robots (Intavis AG, Germany) as described earlier. 44 The following digoxigenin-labeled probes were used: a 656-bp probe specific for A20 (nt 3223-3879 of NM_009397). A sense probe, used as a negative control, showed no positive signal in any of the hybridizations (data not shown). Some samples were embedded in 0.5% gelatin, 30% albumin, 20% sucrose and 2% glutaraldehyde in PBS and sectioned at 30 mm using a vibratome.
Western blotting. Mouse epidermis was separated from dermis after 15 min of incubation in 3.8% ammonium thiocyanate. Epidermal extracts were prepared using lysis buffer containing 5 mM Hepes, 0.1% NP-40, 10% glycerol, 150 mM NaCl and 5 mM EDTA. Epithelia of the mouse embryos were separated from the mesenchyme as described previously. 45 Isolated epithelia were incubated for 6 h in accordance with the hanging drop protocol then harvested in 2% SDS in PBS using syringe and needle. Protein concentration was determined using the BCA Protein Assay kit (Pierce, Rockford, IL, USA) according to the manufacturer instructions. Protein (20 mg) was separated in 10% SDS-PAGE, transferred onto a Hybond-C-extra membrane (Amersham, Uppsala, Sweden), and probed with an anti-A20 antibody (Santa Cruz, Santa Cruz, CA, USA; sc-166692; 1:150) followed by HRP-conjugated anti-mouse secondary antibody (Jackson Laboratories, 1:6000). Blots were developed using enhanced chemiluminescence (SuperSignal West Pico, Thermo Scientific, Asse, Belgium).
